Total revenue of $203 million, up from $5 million in Q1 2020Total programs under contract of 119, up 63% year-over-yearEPS...
AbCellera
VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera (NASDAQ: ABCL), a technology company with a centralized operating system for next-generation antibody discovery, today announced...